Indication
Fasting
7 clinical trials
9 products
Clinical trial
Single-Dose, Randomized, Two-Way Crossover, Bioequivalence of Lamotrigine 100 mg Tablet (Desitin Arzneimittel GmbH, Germany) and Lamictal 100 mg Tablet (GlaxoSmithKline GmbH & Co. KG, Germany) in Healthy, Male Volunteers, FastingStatus: Completed, Estimated PCD: 2023-05-09
Product
LamotrigineProduct
ChemotherapyClinical trial
Use of a Fasting Mimicking Diet in Patients Undergoing Chemotherapy for Gynecologic MalignanciesStatus: Recruiting, Estimated PCD: 2025-09-01
Product
ApixabanClinical trial
A Phase I, Randomized, Single-Dose, Open-Label, Four-Way Crossover Study to Evaluate the Comparative Bioavailability of Apixaban for TAH3311 Oral Dissolving Film Versus ELIQUIS® Oral Tablet in Healthy Male and Female SubjectsStatus: Completed, Estimated PCD: 2022-12-28
Clinical trial
Effectiveness of Diabetes Education and Medication Adjustment With Telemonitoring Intervention in Reducing Diabetes Complications During Ramadan Fasting - a Randomized Control TrialStatus: Completed, Estimated PCD: 2021-09-01
Clinical trial
Effectiveness of a Ramadan-focused Structured Diabetes Tele-education in Reducing Diabetes Complications During Ramadan Fasting in South East AsiaStatus: Recruiting, Estimated PCD: 2025-06-01
Product
Focused diabetes tele-education and medication adjustment based on guidelines with remote monitoringClinical trial
Optimizing Exercise Training Effects on Metabolic Syndrome Factors by Altering the Timing of Medication and Meal IngestionStatus: Recruiting, Estimated PCD: 2024-05-30
Product
Exercise TrainingClinical trial
Effect of Modified, Rapid-start, DOR/3TC/TDF or DOR + FTC/TAF or BIC/FTC/TAF on Body Weight and Composition, Metabolic Risk Parameters, and Measures of Bone Strength in Treatment-Naïve Black and Hispanic Women With HIV-1 InfectionStatus: Withdrawn, Estimated PCD: 2023-05-03
Product
DOR/3TC/TDFProduct
DOR + FTC/TAFProduct
BIC/FTC/TAF